Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with rel-3-(aminosulfonyl)-4-chloro-N-[(2R,6S)- 2,6-dimethyl-1-piperidinyl]benzamide and (5'R)-12'-hydroxy-2'-(1-methylethyl)-5'- (phenylmethyl)ergotaman-3',6',18-trione monomethanesulfonate (salt) (61498-92-8)

Other Product

• Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide,5-ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)- pyrimidinetrione monosodium salt and 2-(phenylmethyl)-1H-benzimidazole
• Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide and 2,3-dihydro-1,4-phthalazinedione dihydrazone sulfate (1:1)
• Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)-
• Yohimban-16-carboxylic acid,11,17-dimethoxy-12-nitro-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)-
• Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with N-[(acetylamino)carbonyl]-2-bromo-2-ethylbutanamide and 3-(2-methylphenoxy)-1,2-propanediol
• Yohimban-16-carboxylic acid,18-hydroxy-17-methoxy-,(3â,16â,17R,- 18â,20R)-
• Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(1-methylethyl)-,(2'â,5'R)-
• Yohimban-16-methanol,18-hydroxy-17- methoxy-,(3â,16â,17R,18â,20R)-
• Yohimban-16-carboxylic acid,18-ethoxy-11,17-dimethoxy-,methyl ester,(3â,16â,17R,18â,20R)-,(2Z)-2-butenedioate
• Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(phenylmethyl)-,(2'â,5'R)-
• Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(phenylmethyl)-,(2'â,5'R,8R)-
• Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(1-methylethyl)-,(2'â,5'R,8R)-
• Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-,methyl ester,(3â,16â,17R,20R)-
• Ergotaman-3',6',18-trione,9,10-dihydro-12'- hydroxy-2',5'-bis(1-methylethyl)-,(2'â,5'R,- 10R)-
• Ergotaman-3',6',18-trione,9,10-dihydro-10,- 12'-dihydroxy-2'-methyl-5'-(phenylmethyl)-,(5'R,8R,10â)-
• Yohimban-16-carboxylic acid,17-hydroxy-,methyl ester,(3â,16R,17R,20R)-
• Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 4-chloro-N(1)-methyl-N(1)-((tetrahydro-2-methyl-2-furanyl)methyl)-1,3-benzenedisulfonamide and 3-hydroxy-alpha-methyl-L-tyrosine
• Cyclopenta[13,17]-18-norandrosta-6,8(14)- dien-11-one,3',4',5',17-tetrahydro-3,5,9- trihydroxy-4'-[(1S,2R)-1-hydroxy-2,3- dimethylbutyl]-3'-methyl-,(3â,3'â,4'â,5â,9â,- 17R)-
• Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(phenylmethyl)-,(5'R)-,(2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt),mixt. with 1-[(4-chlorophenyl)phenylmethyl]- 4-[(3-methylphenyl)methyl]piperazine dihydrochloride and 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione
• Yohimban-16-carboxylic acid, 1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3β,16β,17α,18β,20α)-, compd. with 5-oxo-l-proline (1:2)